{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,8]],"date-time":"2026-01-08T09:34:08Z","timestamp":1767864848481,"version":"3.49.0"},"reference-count":66,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,5,10]],"date-time":"2022-05-10T00:00:00Z","timestamp":1652140800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Med."],"abstract":"<jats:p>Patients undergoing liver transplant (LTX) typically confront a challenging postoperative journey. A dysbiotic gut microbiome is associated with the development of complications, including post-LTX allograft rejection, metabolic diseases and <jats:italic>de novo<\/jats:italic> or recurrent cancer. A major explanation of this are the bipartite interactions between the gut microbiota and host immunity, which modulates the alloimmune response towards the liver allograft. Furthermore, bacterial translocation from dysbiosis causes pathogenic changes in the concentrations of microbial metabolites like lipopolysaccharides, short-chain fatty acids (SCFAs) and Trimethylamine-N-Oxide, with links to cardiovascular disease development and diabetes mellitus. Gut dysbiosis also disrupts bile acid metabolism, with implications for various post-LTX metabolic diseases. Certain taxonomy of microbiota such as lactobacilli, <jats:italic>F.prausnitzii<\/jats:italic> and <jats:italic>Bacteroides<\/jats:italic> appear to be associated with these undesired outcomes. As such, an interesting but as yet unproven hypothesis exists as to whether induction of a \u201cbeneficial\u201d composition of gut microbiota may improve prognosis in LTX patients. Additionally, there are roles of the microbiome as predictive and prognostic indicators for clinicians in improving patient care. Hence, the gut microbiome represents an exceptionally exciting avenue for developing novel prognostic, predictive and therapeutic applications.<\/jats:p>","DOI":"10.3389\/fmed.2022.873523","type":"journal-article","created":{"date-parts":[[2022,5,10]],"date-time":"2022-05-10T08:16:59Z","timestamp":1652170619000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":9,"title":["Predictive and Prognostic Roles of Gut Microbial Variation in Liver Transplant"],"prefix":"10.3389","volume":"9","author":[{"given":"Hon Jen","family":"Wong","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wen Hui","family":"Lim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cheng Han","family":"Ng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Darren Jun Hao","family":"Tan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Glenn K.","family":"Bonney","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alfred W. C.","family":"Kow","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel Q.","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohammad Shadab","family":"Siddiqui","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mazen","family":"Noureddin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicholas","family":"Syn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mark D.","family":"Muthiah","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2022,5,10]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"594","DOI":"10.1111\/ajt.13479","article-title":"Complications and their resolution in recipients of deceased and living donor liver transplants: findings from the A2ALL cohort study","volume":"16","author":"Samstein","year":"2016","journal-title":"Am J Transplant."},{"key":"B2","doi-asserted-by":"publisher","first-page":"16795","DOI":"10.3748\/wjg.v20.i45.16795","article-title":"Microbiota and the gut-liver axis: bacterial translocation, inflammation and infection in cirrhosis","volume":"20","author":"Giannelli","year":"2014","journal-title":"World J Gastroenterol."},{"key":"B3","doi-asserted-by":"publisher","first-page":"1024","DOI":"10.1111\/cmi.12308","article-title":"Defining dysbiosis and its influence on host immunity and disease","volume":"16","author":"Petersen","year":"2014","journal-title":"Cell Microbiol."},{"key":"B4","doi-asserted-by":"publisher","first-page":"58","DOI":"10.3390\/diseases7040058","article-title":"Role of gut dysbiosis in liver diseases: what have we learned so far?","volume":"7","author":"Fukui","year":"2019","journal-title":"Diseases."},{"key":"B5","doi-asserted-by":"publisher","first-page":"752","DOI":"10.1002\/lt.25046","article-title":"Alterations in gut microbial function following liver transplant","volume":"24","author":"Bajaj","year":"2018","journal-title":"Liver Transpl."},{"key":"B6","doi-asserted-by":"publisher","first-page":"668","DOI":"10.1097\/TP.0000000000002568","article-title":"Functional microbiomics in liver transplantation: identifying novel targets for improving allograft outcomes","volume":"103","author":"Kriss","year":"2019","journal-title":"Transplantation."},{"key":"B7","doi-asserted-by":"publisher","first-page":"e0235359","DOI":"10.1371\/journal.pone.0235359","article-title":"Effect of liver transplantation on intestinal permeability and correlation with infection episodes","volume":"15","author":"Ponziani","year":"2020","journal-title":"PLoS ONE."},{"key":"B8","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/S1499-3872(11)60124-0","article-title":"Changes of gut bacteria and immune parameters in liver transplant recipients","volume":"11","author":"Wu","year":"2012","journal-title":"Hepatobiliary Pancreat Dis Int."},{"key":"B9","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1097\/COC.0000000000000239","article-title":"CTLA-4 and PD-1 pathways similarities, differences, and implications of their inhibition","volume":"39","author":"Buchbinder","year":"2016","journal-title":"Am J Clin Oncol."},{"key":"B10","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1016\/0168-8278(95)80433-1","article-title":"Human Kupffer cells secrete IL-10 in response to lipopolysaccharide (LPS) challenge","volume":"22","author":"Knolle","year":"1995","journal-title":"J Hepatol."},{"key":"B11","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1136\/gutjnl-2015-311224","article-title":"Gut microbial translocation corrupts myeloid cell function to control bacterial infection during liver cirrhosis","volume":"66","author":"Hackstein","year":"2017","journal-title":"Gut."},{"key":"B12","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1016\/j.immuni.2011.03.018","article-title":"Interleukin-10 signaling in regulatory T cells is required for suppression of Th17 cell-mediated inflammation","volume":"34","author":"Chaudhry","year":"2011","journal-title":"Immunity."},{"key":"B13","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1007\/s11307-020-01543-3","article-title":"In vivo imaging of local inflammation: monitoring LPS-induced CD80\/CD86 upregulation by PET","volume":"23","author":"Taddio","year":"2021","journal-title":"Mol Imaging Biol."},{"key":"B14","doi-asserted-by":"publisher","first-page":"7659462","DOI":"10.1155\/2017\/7659462","article-title":"CD80 expressed by CD8+ T cells contributes to PD-L1-induced apoptosis of activated CD8+ T cells","volume":"2017","author":"Rollins","year":"2017","journal-title":"J Immunol Res."},{"key":"B15","doi-asserted-by":"publisher","first-page":"eaau9079","DOI":"10.1126\/sciimmunol.aau9079","article-title":"Diet modulates colonic T cell responses by regulating the expression of a Bacteroides thetaiotaomicron antigen","volume":"4","author":"Wegorzewska","year":"2019","journal-title":"Sci Immunol."},{"key":"B16","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1038\/nature10434","article-title":"Peripheral education of the immune system by colonic commensal microbiota","volume":"478","author":"Lathrop","year":"2011","journal-title":"Nature."},{"key":"B17","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.cellimm.2019.01.005","article-title":"Mesenteric lymph node CD4 + T lymphocytes migrate to liver and contribute to non-alcoholic fatty liver disease","volume":"337","author":"Su","year":"2019","journal-title":"Cell Immunol."},{"key":"B18","doi-asserted-by":"publisher","first-page":"1662","DOI":"10.1002\/hep.24253","article-title":"Paneth cell-derived interleukin-17A causes multiorgan dysfunction after hepatic ischemia and reperfusion injury","volume":"53","author":"Park","year":"2011","journal-title":"Hepatology."},{"key":"B19","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1016\/j.cell.2009.09.033","article-title":"Induction of intestinal Th17 cells by segmented filamentous bacteria","volume":"139","author":"Ivanov","year":"2009","journal-title":"Cell."},{"key":"B20","doi-asserted-by":"publisher","first-page":"2839232","DOI":"10.1155\/2016\/2839232","article-title":"Interferon tau affects mouse intestinal microbiota and expression of IL-17","volume":"2016","author":"Ren","year":"2016","journal-title":"Med Inflammation."},{"key":"B21","doi-asserted-by":"publisher","first-page":"2241","DOI":"10.1042\/CS20180662","article-title":"Degranulation of gastrointestinal mast cells contributes to hepatic ischemia-reperfusion injury in mice","volume":"132","author":"He","year":"2018","journal-title":"Clin Sci."},{"key":"B22","doi-asserted-by":"publisher","first-page":"2965","DOI":"10.1016\/j.ajpath.2014.07.014","article-title":"The microbiota protects against ischemia\/reperfusion-induced intestinal injury through nucleotide-binding oligomerization domain-containing protein 2 (NOD2) signaling","volume":"184","author":"Perez-Chanona","year":"2014","journal-title":"Am J Pathol."},{"key":"B23","doi-asserted-by":"publisher","first-page":"1714","DOI":"10.1111\/jcmm.14069","article-title":"Alteration in gut microbiota caused by time-restricted feeding alleviate hepatic ischaemia reperfusion injury in mice","volume":"23","author":"Ren","year":"2019","journal-title":"J Cell Mol Med."},{"key":"B24","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1016\/j.apsb.2021.05.029","article-title":"The gut microbial metabolite, 3,4-dihydroxyphenylpropionic acid, alleviates hepatic ischemia\/reperfusion injury via mitigation of macrophage pro-inflammatory activity in mice","volume":"12","author":"Li","year":"2021","journal-title":"Acta Pharm Sin B"},{"key":"B25","doi-asserted-by":"publisher","first-page":"614","DOI":"10.1111\/ajt.16219","article-title":"Ischemia-reperfusion injury and its relationship with early allograft dysfunction in liver transplant patients","volume":"21","author":"Ito","year":"2021","journal-title":"Am J Transplant."},{"key":"B26","doi-asserted-by":"publisher","first-page":"4107","DOI":"10.4049\/jimmunol.0902580","article-title":"Dynamic regulation of CD8 T cell tolerance induction by liver sinusoidal endothelial cells","volume":"184","author":"Schurich","year":"2010","journal-title":"J Immunol."},{"key":"B27","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1016\/j.cyto.2012.10.026","article-title":"Intracellular IFN-\u03b3 and IL-2 expression monitoring as surrogate markers of the risk of acute rejection and personal drug response in de novo liver transplant recipients","volume":"61","author":"Mill\u00e1n","year":"2013","journal-title":"Cytokine."},{"key":"B28","doi-asserted-by":"publisher","first-page":"1125","DOI":"10.1016\/j.cell.2016.10.020","article-title":"Linking the human gut microbiome to inflammatory cytokine production capacity","volume":"167","author":"Schirmer","year":"2016","journal-title":"Cell."},{"key":"B29","doi-asserted-by":"publisher","first-page":"143","DOI":"10.3389\/fimmu.2019.00143","article-title":"Faecalibacterium prausnitzii skews human DC to prime IL10-producing T cells through TLR2\/6\/JNK signaling and IL-10, IL-27, CD39, and IDO-1 induction","volume":"10","author":"Alameddine","year":"2019","journal-title":"Front Immunol."},{"key":"B30","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1124\/dmd.118.084772","article-title":"Commensal gut bacteria convert the immunosuppressant tacrolimus to less potent metabolites","volume":"47","author":"Guo","year":"2019","journal-title":"Drug Metab Dispos."},{"key":"B31","doi-asserted-by":"publisher","first-page":"8309","DOI":"10.3390\/ijms22158309","article-title":"The gut microbiota-derived immune response in chronic liver disease","volume":"22","author":"Won","year":"2021","journal-title":"Int J Mol Sci."},{"key":"B32","doi-asserted-by":"publisher","first-page":"5","DOI":"10.3978\/j.issn.2305-5839.2014.12.06","article-title":"Recent advances in the development of farnesoid X receptor agonists","volume":"3","author":"Ali","year":"2015","journal-title":"Ann Transl Med."},{"key":"B33","doi-asserted-by":"publisher","first-page":"2124","DOI":"10.3390\/nu12072124","article-title":"Compound 18 improves glucose tolerance in a hepatocyte TGR5-dependent manner in mice","volume":"12","author":"Holter","year":"2020","journal-title":"Nutrients."},{"key":"B34","doi-asserted-by":"publisher","first-page":"1761","DOI":"10.2337\/db06-1491","article-title":"Metabolic endotoxemia initiates obesity and insulin resistance","volume":"56","author":"Cani","year":"2007","journal-title":"Diabetes."},{"key":"B35","doi-asserted-by":"publisher","first-page":"e0071108","DOI":"10.1371\/journal.pone.0071108","article-title":"Human gut microbiota changes reveal the progression of glucose intolerance","volume":"8","author":"Zhang","year":"2013","journal-title":"PLoS ONE."},{"key":"B36","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1093\/toxsci\/kfy208","article-title":"Gut microbiota modulates interactions between polychlorinated biphenyls and bile acid homeostasis","volume":"166","author":"Cheng","year":"2018","journal-title":"Toxicol Sci."},{"key":"B37","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1038\/s41598-017-18305-x","article-title":"Reprogramming of pro-inflammatory human macrophages to an anti-inflammatory phenotype by bile acids","volume":"8","author":"Wammers","year":"2018","journal-title":"Sci Rep."},{"key":"B38","doi-asserted-by":"publisher","first-page":"32","DOI":"10.3390\/medsci6020032","article-title":"The role of gut microbiota in obesity and type 2 and type 1 diabetes mellitus: new insights into \u201cold\u201d diseases","volume":"6","author":"Harsch","year":"2018","journal-title":"Med Sci."},{"key":"B39","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1016\/0005-2760(65)90164-5","article-title":"Enzymes of lipid synthesis in the liver of the cortisone-treated rat","volume":"98","author":"Hays","year":"1965","journal-title":"Biochim Biophys Acta."},{"key":"B40","first-page":"648","article-title":"Plasma post-heparin lipolytic activity and triglyceride clearance in uremic and hemodialysis patients and renal allograft recipients","volume":"87","author":"Ibels","year":"1976","journal-title":"J Lab Clin Med."},{"key":"B41","doi-asserted-by":"publisher","first-page":"110503","DOI":"10.1016\/j.biopha.2020.110503","article-title":"Gut microbiota-derived short-chain fatty acids and hypertension: mechanism and treatment","volume":"130","author":"Yang","year":"2020","journal-title":"Biomed Pharmacother."},{"key":"B42","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1161\/HYPERTENSIONAHA.110.154567","article-title":"HDAC inhibition attenuates inflammatory, hypertrophic and hypertensive responses in spontaneously hypertensive rats","volume":"56","author":"Cardinale","year":"2010","journal-title":"Hypertension."},{"key":"B43","doi-asserted-by":"publisher","first-page":"102649","DOI":"10.1016\/j.ebiom.2020.102649","article-title":"The gut microbiome in coronary artery disease and heart failure: current knowledge and future directions","volume":"52","author":"Tr\u00f8seid","year":"2020","journal-title":"EBioMedicine."},{"key":"B44","doi-asserted-by":"publisher","first-page":"1709","DOI":"10.1194\/jlr.M087239","article-title":"Simultaneous inhibition of FXR and TGR5 exacerbates atherosclerotic formation","volume":"59","author":"Miyazaki-Anzai","year":"2018","journal-title":"J Lipid Res."},{"key":"B45","first-page":"146","article-title":"Endogenous hydrogen sulfide and the cardiovascular system-what's the smell all about?","volume":"29","author":"Pearson","year":"2006","journal-title":"Clin Invest Med."},{"key":"B46","doi-asserted-by":"publisher","first-page":"4249","DOI":"10.1038\/s41598-019-40638-y","article-title":"Trimethylamine N-oxide, circulating endothelial progenitor cells, and endothelial function in patients with stable angina","volume":"9","author":"Chou","year":"2019","journal-title":"Sci Rep."},{"key":"B47","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1007\/s10753-015-0261-7","article-title":"Trimethylamine-N-oxide treatment induces changes in the ATP-binding cassette transporter a1 and scavenger receptor A1 in murine macrophage J774A.1 cells","volume":"39","author":"Mohammadi","year":"2016","journal-title":"Inflammation."},{"key":"B48","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1016\/j.ccr.2012.02.007","article-title":"Promotion of hepatocellular carcinoma by the intestinal microbiota and TLR4","volume":"21","author":"Dapito","year":"2012","journal-title":"Cancer Cell."},{"key":"B49","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1152\/ajpgi.00434.2013","article-title":"Epiregulin promotes the emergence and proliferation of adult liver progenitor cells","volume":"307","author":"Tomita","year":"2014","journal-title":"Am J Physiol Gastrointest Liver Physiol."},{"key":"B50","doi-asserted-by":"publisher","first-page":"1186","DOI":"10.18632\/oncotarget.27532","article-title":"Origin and role of hepatic myofibroblasts in hepatocellular carcinoma","volume":"11","author":"Yavuz","year":"2020","journal-title":"Oncotarget."},{"key":"B51","doi-asserted-by":"publisher","first-page":"5931","DOI":"10.1126\/science.aan5931","article-title":"Gut microbiome-mediated bile acid metabolism regulates liver cancer via NKT cells","volume":"360","author":"Ma","year":"2018","journal-title":"Science."},{"key":"B52","doi-asserted-by":"publisher","first-page":"10589","DOI":"10.1038\/s41598-021-89963-1","article-title":"Profiling of tumour-associated microbiota in human hepatocellular carcinoma","volume":"11","author":"Komiyama","year":"2021","journal-title":"Sci Rep."},{"key":"B53","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1159\/000462969","article-title":"Early detection of hepatocellular carcinoma recurrence using the highly sensitive fucosylated fraction of alpha-fetoprotein","volume":"11","author":"Setsu","year":"2017","journal-title":"Case Rep Gastroenterol."},{"key":"B54","doi-asserted-by":"publisher","first-page":"1277","DOI":"10.1002\/lt.23531","article-title":"Burden of de novo malignancy in the liver transplant recipient","volume":"18","author":"Chandok","year":"2012","journal-title":"Liver Transpl."},{"key":"B55","doi-asserted-by":"publisher","first-page":"570","DOI":"10.1016\/j.ccell.2018.03.015","article-title":"The influence of the gut microbiome on cancer, immunity, and cancer immunotherapy","volume":"33","author":"Gopalakrishnan","year":"2018","journal-title":"Cancer Cell."},{"key":"B56","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1126\/science.aan3706","article-title":"Gut microbiome influences efficacy of PD-1\u2013based immunotherapy against epithelial tumors","volume":"359","author":"Routy","year":"2018","journal-title":"Science."},{"key":"B57","doi-asserted-by":"publisher","first-page":"720842","DOI":"10.3389\/fonc.2021.720842","article-title":"The role of gut microbiota in lung cancer: from carcinogenesis to immunotherapy","volume":"11","author":"Liu","year":"2021","journal-title":"Front Oncol."},{"key":"B58","doi-asserted-by":"publisher","first-page":"1518","DOI":"10.3389\/fmicb.2019.01518","article-title":"Fecal microbiome data distinguish liver recipients with normal and abnormal liver function from healthy controls","volume":"10","author":"Lu","year":"2019","journal-title":"Front Microbiol."},{"key":"B59","doi-asserted-by":"publisher","first-page":"844","DOI":"10.1097\/TP.0000000000000334","article-title":"Intestinal microbial variation may predict early acute rejection after liver transplantation in rats","volume":"98","author":"Ren","year":"2014","journal-title":"Transplantation."},{"key":"B60","doi-asserted-by":"publisher","first-page":"1355","DOI":"10.4254\/wjh.v7.i10.1355","article-title":"Review on immunosuppression in liver transplantation","volume":"7","author":"Moini","year":"2015","journal-title":"World J Hepatol."},{"key":"B61","doi-asserted-by":"publisher","first-page":"1758835919848184","DOI":"10.1177\/1758835919848184","article-title":"Diagnostic and therapeutic potential of the gut microbiota in patients with early hepatocellular carcinoma","volume":"11","author":"Ponziani","year":"2019","journal-title":"Ther Adv Med Oncol."},{"key":"B62","doi-asserted-by":"publisher","first-page":"758","DOI":"10.1002\/phar.2130","article-title":"Efficacy and safety of probiotics and synbiotics in liver transplantation","volume":"38","author":"Jorgenson","year":"2018","journal-title":"Pharmacotherapy."},{"key":"B63","doi-asserted-by":"publisher","first-page":"294","DOI":"10.3350\/cmh.2020.0057","article-title":"Fecal microbiota transplantation in alcohol related liver diseases","volume":"26","author":"Shasthry","year":"2020","journal-title":"Clin Mol Hepatol."},{"key":"B64","doi-asserted-by":"publisher","first-page":"330","DOI":"10.3390\/jcm10020330","article-title":"Gut microbiota modulation and fecal transplantation: an overview on innovative strategies for hepatic encephalopathy treatment","volume":"10","author":"Hassouneh","year":"2021","journal-title":"J Clin Med."},{"key":"B65","doi-asserted-by":"publisher","first-page":"3871","DOI":"10.3748\/wjg.v24.i34.3871","article-title":"Optimal immunosuppressor induces stable gut microbiota after liver transplantation","volume":"24","author":"Jiang","year":"2018","journal-title":"World J Gastroenterol."},{"key":"B66","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1007\/s13300-018-0374-8","article-title":"Post-Liver transplantation diabetes mellitus: a review of relevance and approach to treatment","volume":"9","author":"Pel\u00e1ez-Jaramillo","year":"2018","journal-title":"Diabetes Ther."}],"container-title":["Frontiers in Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2022.873523\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,5,10]],"date-time":"2022-05-10T08:17:03Z","timestamp":1652170623000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2022.873523\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5,10]]},"references-count":66,"alternative-id":["10.3389\/fmed.2022.873523"],"URL":"https:\/\/doi.org\/10.3389\/fmed.2022.873523","relation":{},"ISSN":["2296-858X"],"issn-type":[{"value":"2296-858X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,5,10]]},"article-number":"873523"}}